[1]刘岘,许乙凯,叶靖.生物素-亲和素系统在MR靶向成像中的应用[J].南方医科大学学报,2004,(10):1130-1132.
 LIU Xian,XU Yi-kai,YE Jing.Application of biotin-avidin system in targeted magnetic resonance imaging[J].,2004,(10):1130-1132.
点击复制

生物素-亲和素系统在MR靶向成像中的应用()
分享到:

《南方医科大学学报》[ISSN:/CN:]

卷:
期数:
2004年10期
页码:
1130-1132
栏目:
出版日期:
2004-10-01

文章信息/Info

Title:
Application of biotin-avidin system in targeted magnetic resonance imaging
作者:
刘岘 许乙凯 叶靖
南方医科大学南方医院影像中心, 广东, 广州, 510515
Author(s):
LIU Xian XU Yi-kai YE Jing
关键词:
生物素-亲和素系统链霉亲和素磁共振成像单克隆抗体
Keywords:
biotin-avidin systemstreptavidinmagnetic resonance imagingmonoclonal antibody
分类号:
R445.2;R735.7
摘要:
目的 探讨利用生物素-亲和素系统的靶向定位效应和生物放大作用,提高MR分子成像的敏感性。方法 制备生物素化HAb18单克隆抗体并测定其生物素化程度及抗原结合活性。将8只荷人肝细胞癌裸鼠静脉注射生物素化单克隆抗体600?g,24h后腹腔注射80?g亲和素,30min后再静脉给予Gd-DTPA-链霉亲和素。对实验动物行MR扫描,测量SET1WI平扫及增强后10、30min及2、6、12、24h图像内肿瘤、肝脏、肌肉的信号强度,绘制信号强度-时间曲线,并计算其强化率及对比度噪声比。结果 HAb18单克隆抗体经生物素化后,每个抗体分子平均可结合20个分子生物素,其抗原结合活性约为91%。增强后肿瘤信号强度缓慢升高,在注射对比剂后第6小时,肿瘤的强化率、比度噪声比达到最大值,与其他各时间点有显著性差异。肝脏在注射对比剂后第6小时的信号强度达到最高,而后信号强度下降,增强后12h的信号强度与平扫相似。肌肉表现为轻度强化,增强后各时间点的信号强度与平扫相比无明显差异。结论 利用生物素-亲和素技术对肿瘤进行MR靶向成像,具有特异性强化作用并能延长肿瘤的强化时间,但Gd-DTPA-SA的血池效应也造成了肝脏的持续强化。
Abstract:
Objective To improve the sensitivity of magnetic resonance molecular(MR) imaging on the basis of the targeting and magnifying effects of biotin-avidin system.Methods Biotinylated monoclonal antibody HAb18 was prepared,and the number of biotin molecules coupled to each antibody molecule was assayed together with the binding capacity of the biotinylated antibody. HAb18 was intravenously injected into 8 BALB/c nude mice bearing QGY-7723 tumor cells,followed by administration of 80? g avidin as the chaser 24 h later and then Gd-DTAP-streptavidin injection after another 30 min. MR imaging was performed before and 10,30,60 min and 3,6,12,and 24 h after the injection of the contrast agents. All the images were obtained using SE T1-weighted imaging sequence. The enhancement time course of the tumor,liver and muscles were determined by measuring the signal intensity (SI) in the region of interest in the tumor,and the enhancement ratio and contrast-to- noise ratio (CNR) of the tumor also calculated. Results On average,20 biotin molecules conjugated with each monoclonal antibody molecule,and the immunoactivity of the biotinylated antibody reached 91%. The SI of the tumor increased slowly and peaked at 6 h after injection of Gd-DTPA-streptavidin,when the enhancement ratio and CNR of the tumor were significantly higher then those measured on other time points. The SI of the liver reached the maximum value at 6 h after injection of the contrast agent,and then declined to the non-enhanced level 12 h after injection. The SI of the muscle exhibited no significant difference after enhancement.Conclusions In targeted MR of the tumor,biotin-avidin system produces specific and prolonged enhancement of the signals,but blood pool effect of Gd-DTPA-streptavidin also causes prolonged enhancement of the liver.

参考文献/References:

[1] Hnatowich DJ,Virzi F,Rusckowski M.Investigation of avidin and biotin for imaging application[J].J Nucl Med,1987,28(8):1294-302.
[2] 刘岘,许乙凯,黄其鎏.新型磁共振靶向对比剂Gd-DTPA-链霉亲和素的制备及其反应条件的实验研究[J].第一军医大学学报,2004,24(1):15-7.Liu X,Xu YK,Huang QL.Preparation of a novel targeted MR contrast agent Gd-DTPA-streptavidin and exploration of its reaction conditions[J].J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao,2004,24(1):15-7.
[3] Diamandis EP,Christopoulos TK.The biotin-(strept) avidin system:principles and applications in biotechnology [J].Clin Chem,1991,37(6):625-36.
[4] Weinmann HJ,Ebert W,Misselwitz B,et al.Tissue-specific MR contrast agents [J].Eur J Radiol,2003,46(1):33-44.
[5] Earls JP,Bluemke DA.New MR imaging contrast agents [J].Magn Reson Imaging Clin N Am,1999,7(3):255-73.
[6] Paganelli G,Bartolomei M,Ferrari M,et al.Pre-targeted locoregional radioimmunotherapy with 90Y-biotin in glioma patients:phase I study and preliminary therapeutic results [J].Cancer Biother Radiopharm,2001,16(3):227-35.
[7] Paganelli G,Grana C,Chinol M,et al.Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin[J].Eur J Nucl Med,1999,26(4):348-57.
[8] Wang H,Pevsner J.Detection of endogenous biotin in various tissues:novel functions in the hippocampus and implication for its use in avidin-biotin technology[J].Cell Tissue Res,1999,296(6):511-6.
[9] Ferro-Flores G,Promentel-Gonzalez G,Gonzalez-Zavala MA,et al.Preparation,biodistribution and dosimetry of 188Re-labeled MoAb ior ceal and its F(ab′)2 fragments by avidin-biotin strategy [J].Nucl Med Biol,1999,26(1):57-62.
[10] Zhang M,Skahara H,Yao Z,et al.Intravenous avidin chase improved localization of radiolabeled streptavidin in intraperitoneal xenograft pretargeted with biotinylated antibody[J].Nucl Med Biol,1997,24(4):61-4.

相似文献/References:

[1]刘岘,许乙凯,黄其鎏.新型磁共振靶向对比剂Gd-DTPA-链霉亲和素的制备及其反应条件的实验研究[J].南方医科大学学报,2004,(01):15.
 LIU Xian,XU Yi-kai,HUANG Qi-liu.Preparation of a novel targeted MR contrast agent Gd-DTPA-streptavidin and exploration of its reaction conditions[J].,2004,(10):15.

备注/Memo

备注/Memo:
收稿日期:2004-2-23。
基金项目:国家自然科学基金(30371608);广东省自然科学基金(020053)
作者简介:刘蚬(1974- ),男,2004年毕业于第一军医大学,博士,主治医师,电话:020-61642086,E-mail:liuxian@fimmu.com
更新日期/Last Update: 1900-01-01